human umbilical cord blood derived mesenchymal stem cells
Sponsors
Medipost Co Ltd., Samsung Medical Center
Conditions
Alzheimer's Disease
Phase 1
Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease
CompletedNCT02054208
Start: 2014-03-31End: 2019-12-31Updated: 2020-08-28
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
CompletedNCT03172117
Start: 2017-05-19End: 2022-03-18Updated: 2023-03-15